Moldable
-
Biologics
Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable and Morpheus Moldable Products
Agilon Moldable Morpheus Moldable IRVINE, Calif. — May 8, 2024 — Irvine-based Biogennix, LLC an osteobiologics company specializing in bone…
Read More » -
Biologics
PUR Biologics Announces Launch of PURcore™, a bioActive Moldable Synthetic for Spine Surgery
IRVINE, CA., April 6, 2023 /OrthoSpineNews/ – PUR Biologics, a subsidiary of HippoFi, Inc. (OTC Pink: ORHB), is proud to…
Read More » -
Biologics
Biogennix’s Agilon Moldable Bone Graft Solution Achieves Sales Surge Amid Adoption by Foot and Ankle Surgeons
IRVINE, Calif. — May 19, 2021 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft…
Read More » -
Biologics
Surgalign Holdings Announce the Commercial Launch of ViBone® Moldable and the First Clinical Implantation
DEERFIELD, Ill., Jan. 12, 2021 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on…
Read More » -
Biologics
Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable Bone Grafting Solution in Spine Procedures
March 04, 2020 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More »